Mannequin-Based Simulation

Mannequin-Based Simulation


Global Mannequin-Based Simulation Market to Reach US$6.1 Billion by 2030

The global market for Mannequin-Based Simulation estimated at US$2.2 Billion in the year 2023, is expected to reach US$6.1 Billion by 2030, growing at a CAGR of 15.9% over the analysis period 2023-2030. Patient Simulators, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Other Product Types segment is estimated at 16.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$892.3 Million While China is Forecast to Grow at 18.9% CAGR

The Mannequin-Based Simulation market in the U.S. is estimated at US$892.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$347.4 Million by the year 2030 trailing a CAGR of 18.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.4% and 14.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.1% CAGR.

Global Mannequin-Based Simulation Market - Key Trends & Drivers Summarized

Mannequin-based simulation is a vital component in medical education and training, providing a realistic and controlled environment for healthcare professionals to practice and hone their skills. These simulations use high-fidelity mannequins that can mimic human physiological responses, such as breathing, heartbeats, and even verbal communication. Mannequin-based simulation allows for the rehearsal of complex medical procedures, the practice of emergency responses, and the improvement of clinical decision-making skills without risking patient safety. This method of training has become increasingly important as medical procedures become more sophisticated and the need for highly skilled healthcare providers grows.

The adoption of mannequin-based simulation in medical training has grown due to advancements in technology and the recognition of its effectiveness. Modern simulation mannequins are highly advanced, capable of simulating a wide range of medical conditions and scenarios with realistic accuracy. This technology provides invaluable hands-on experience, enabling trainees to practice and repeat procedures until they achieve proficiency. Furthermore, mannequin-based simulations are used for interdisciplinary training, promoting teamwork and communication among healthcare professionals. This holistic approach to medical education helps bridge the gap between theoretical knowledge and practical skills, ultimately leading to better patient outcomes.

The growth in the mannequin-based simulation market is driven by several factors. Firstly, the increasing complexity of medical procedures and the need for precision and competence have made simulation-based training essential. Secondly, advancements in mannequin technology, including improved realism and interactivity, have enhanced the training experience and outcomes. Thirdly, there is a growing emphasis on patient safety and the reduction of medical errors, which has led to the widespread adoption of simulation training in medical curricula. Lastly, the ongoing shortage of clinical training sites and the need for efficient, scalable training solutions have further propelled the demand for mannequin-based simulation. These factors collectively ensure the continued expansion and innovation within the mannequin-based simulation market.

Select Competitors (Total 55 Featured) -
  • Moog, Inc.
  • Laerdal Medical AS
  • Ambu A/S
  • 3B Scientific GmbH
  • Cardionics
  • DentalEZ, Inc.
  • Gaumard Scientific Co., Inc.
  • IngMar Medical
  • Kyoto Kagaku Co., Ltd.
  • Mentice AB
  • CAE Healthcare
  • Adam Rouilly Ltd.
  • Global Technologies
  • KOKEN CO., LTD.
  • LifeCast Body Simulation Ltd.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Economic Update
COVID-19 Impact on Mannequin-Based Simulation
Mannequin - A Prelude
Simulation Based Education
Nursing Education Embraces Simulation-based Learning in a Major Way
Mannequin-based Simulation: An Integral Part of Medical Simulation Market
Global Mannequin-based Simulation Market Set to Witness Significant Growth
Growth Drivers
Increasing Focus on Patient Safety
Limited Access to Live Patients Drives Market for Simulation
Simulation in Healthcare Enables Cost Reduction
Technology Revolution Drives Demand for Simulation
Affordability & Rising Implementation to Boost Demand
Developed Regions: Primary Revenue Contributors
Developing Regions Offer High Growth Potential for Mannequin-based Simulation
Patient Simulators Lead the Mannequin-based Simulation Market
Competition
Mannequin-Based Simulation - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increase in Surgeries Augurs Well for Market Growth
Global Surgical Procedure Volume by Procedure Type
Rise in Number of Surgeries & Shortage of Surgeons Drive Use of Mannequin-based Simulation for Surgeon Education and Training
Surgical Backlog & Surgeon Shortages: A Harrowing Situation
Cancer Surgery Demand Surges Amid Surgeon Shortage
Mannequin-based Simulation to the Rescue
As the Number of Surgeries Performed Globally Increase, the Need for Well Trained Surgeons Becomes Acute, Strengthening the Business Case for Mannequin-based Simulation: Global Market for General Surgery (In US$ Billion) for Years 2018, 2020, 2022, 2024, 2026 and 2028
Virtual Simulation and High-Fidelity Mannequin Simulation for Recognizing Critical Events
High-fidelity Mannequins
Advanced Mannequins Imitate Human Reactions
Increasing Healthcare Expenditure to Foster Growth
World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
Mannequin-based Simulation for Nursing Schools
Cardiology, a Promising Field for Medical Animation/Simulation
Simulation Benefits Interventional Cardiology
Mannequins Gain Traction in Military Medical Training
Minimally-invasive Procedures Necessitate Simulation-based Training
Robot-assisted Surgical Simulation Training Gaining Significance
Simulation Training Preferred for Cataract Surgery
Surgical Simulation Gets Notable Makeover with Influx of Innovative Approaches
Surgical Simulation: The History & Evolution
Existing Surgical Simulation Models
Continuing Advances Pave Way for Versatile & Realistic Surgical Simulators
Innovations Set to Take Surgical Simulation to Next Level
Select Innovations
Learning Theories Guiding Development of Simulation-based Education
Areas where Under Graduate Nursing Education Simulation is Most Used
Virtual Simulations for UG Nursing Programs
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Mannequin-Based Simulation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Mannequin-Based Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Mannequin-Based Simulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Patient Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Patient Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Patient Simulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Academics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Mannequin-Based Simulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 21: USA Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: USA 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
TABLE 23: USA Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 26: Canada Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: Canada Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: Canada 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
TABLE 29: Canada Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
TABLE 32: Japan Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: Japan Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: Japan 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
TABLE 35: Japan Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
TABLE 38: China Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: China Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: China 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
TABLE 41: China Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Mannequin-Based Simulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 44: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 45: Europe Historic Review for Mannequin-Based Simulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Europe 16-Year Perspective for Mannequin-Based Simulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 47: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
TABLE 53: France Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: France Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: France 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
TABLE 56: France Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
TABLE 59: Germany Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Germany Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Germany 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
TABLE 62: Germany Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 65: Italy Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Italy Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Italy 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
TABLE 68: Italy Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
TABLE 71: UK Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: UK Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: UK 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
TABLE 74: UK Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Rest of Europe Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Rest of Europe 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Rest of Europe Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Rest of Europe 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Asia-Pacific Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Asia-Pacific 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Asia-Pacific Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Asia-Pacific 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 89: Rest of World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Rest of World Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Rest of World 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
TABLE 92: Rest of World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of World Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of World 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings